Mednax Inc (MD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mednax Inc (MD) has a cash flow conversion efficiency ratio of 0.142x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($125.32 Million) by net assets ($880.98 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MD stock market capitalisation for the company's overall valuation and market capitalisation.
Mednax Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Mednax Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Mednax Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mednax Inc ranked by their cash flow conversion efficiency. Explore MD cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
V2X Inc
NYSE:VVX
|
0.037x |
|
Whirlpool Corporation
NYSE:WHR
|
-0.031x |
|
Empresas Cablevisión S.A.B. de C.V
MX:CABLECPO
|
0.177x |
|
Foran Energy Group Co Ltd
SHE:002911
|
-0.014x |
|
Alignment Healthcare LLC
NASDAQ:ALHC
|
-0.065x |
|
Jiangxi Special Electric Motor Co Ltd
SHE:002176
|
-0.004x |
|
LTC Properties Inc
NYSE:LTC
|
0.049x |
|
HeiLongJiang Kingland Technology Co Ltd
SHE:000711
|
-0.013x |
Annual Cash Flow Conversion Efficiency for Mednax Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Mednax Inc from 1994 to 2025. View Mednax Inc (MD) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $865.85 Million | $271.09 Million | 0.313x | +15.94% |
| 2024-12-31 | $764.94 Million | $206.57 Million | 0.270x | +66.97% |
| 2023-12-31 | $849.06 Million | $137.32 Million | 0.162x | -13.62% |
| 2022-12-31 | $891.63 Million | $166.94 Million | 0.187x | +118.78% |
| 2021-12-31 | $896.69 Million | $76.74 Million | 0.086x | -68.73% |
| 2020-12-31 | $747.72 Million | $204.62 Million | 0.274x | +18.34% |
| 2019-12-31 | $1.50 Billion | $346.64 Million | 0.231x | +146.29% |
| 2018-12-31 | $3.09 Billion | $289.93 Million | 0.094x | -43.70% |
| 2017-12-31 | $3.07 Billion | $511.38 Million | 0.167x | +3.75% |
| 2016-12-31 | $2.76 Billion | $443.78 Million | 0.161x | +6.28% |
| 2015-12-31 | $2.44 Billion | $368.70 Million | 0.151x | -18.93% |
| 2014-12-31 | $2.27 Billion | $422.64 Million | 0.187x | +7.82% |
| 2013-12-31 | $2.34 Billion | $405.40 Million | 0.173x | +8.13% |
| 2012-12-31 | $2.04 Billion | $325.69 Million | 0.160x | +2.20% |
| 2011-12-31 | $1.73 Billion | $271.02 Million | 0.157x | -5.79% |
| 2010-12-31 | $1.45 Billion | $240.56 Million | 0.166x | -18.06% |
| 2009-12-31 | $1.19 Billion | $241.37 Million | 0.203x | +7.91% |
| 2008-12-31 | $965.14 Million | $181.39 Million | 0.188x | -4.39% |
| 2007-12-31 | $959.05 Million | $188.52 Million | 0.197x | -3.99% |
| 2006-12-31 | $865.80 Million | $177.27 Million | 0.205x | -12.79% |
| 2005-12-31 | $691.79 Million | $162.42 Million | 0.235x | +8.33% |
| 2004-12-31 | $571.03 Million | $123.75 Million | 0.217x | +5.09% |
| 2003-12-31 | $572.38 Million | $118.03 Million | 0.206x | +15.50% |
| 2002-12-31 | $548.00 Million | $97.84 Million | 0.179x | -5.36% |
| 2001-12-31 | $478.85 Million | $90.34 Million | 0.189x | +26.24% |
| 2000-12-31 | $241.90 Million | $36.15 Million | 0.149x | +42.53% |
| 1999-12-31 | $228.90 Million | $24.00 Million | 0.105x | -35.66% |
| 1998-12-31 | $207.40 Million | $33.80 Million | 0.163x | -8.01% |
| 1997-12-31 | $163.70 Million | $29.00 Million | 0.177x | +63.15% |
| 1996-12-31 | $136.30 Million | $14.80 Million | 0.109x | +15.58% |
| 1995-12-31 | $62.80 Million | $5.90 Million | 0.094x | -71.99% |
| 1994-12-31 | $16.10 Million | $5.40 Million | 0.335x | -- |
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners,… Read more